PRISM Mid-Day Movers: Healthcate and Mental Health are Leading Today’s Indexes
Shares of Hims & Hers Health, Inc. (NYSE: HIMS) are ripping higher today, jumping about 37% to $21.61 as the telehealth platform continues to rebound from its February selloff and investors refocus on its longer‑term growth story beyond GLP‑1 weight‑loss headlines. The move comes on massive volume of more than 104 million shares, far above its typical trading activity, and follows a strong 2025 print with revenue up roughly 59% to about $2.35 billion, positive net income, and 2026 guidance calling for another year of double‑digit top‑line growth even as the company faces regulatory and legal scrutiny around its compounded GLP‑1 offerings.
Shares of Relmada Therapeutics, Inc. (ticker: RLMD) are climbing again today, recently up about 34% as buyers continue to lean into the company’s emerging oncology story and strengthened balance sheet. The move extends a powerful multi‑week rally sparked by positive early‑stage results for NDV‑01 in non‑muscle‑invasive bladder cancer and a sizable recent capital raise that, together, give Relmada a clearer, better‑funded path toward planned Phase 3 trials and potential value‑creating catalysts ahead.
Other Notable Movers:
uniQure N.V. (QURE) up 24%
Polaryx Therapeutics (PLYX) up 25%
Brand Engagement Network, Inc. (BNAI) down -22%
